Assessment
dupilumab
Children aged 6 to 11 years with severe atopic dermatitis for whom systemic therapy is being considered
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relationsAssessment
Children aged 6 to 11 years with severe atopic dermatitis for whom systemic therapy is being considered
Connected evidence
2 relations